4.5 Review

Targeted immunomodulation using antigen- conjugated nanoparticles

出版社

WILEY
DOI: 10.1002/wnan.1263

关键词

-

资金

  1. National Institutes of Health
  2. National Institute of Diabetes And Digestive and Kidney Diseases [T32DK077662]
  3. National Multiple Sclerosis Society
  4. Juvenile Diabetes Research Foundation
  5. Paralyzed Veterans of America
  6. Myelin Repair Foundation

向作者/读者索取更多资源

The growing prevalence of nanotechnology in the fields of biology, medicine, and the pharmaceutical industry is confounded by the relatively small amount of data on the impact of these materials on the immune system. In addition to concerns surrounding the potential toxicity of nanoparticle (NP)-based delivery systems, there is also a demand for a better understanding of the mechanisms governing interactions of NPs with the immune system. Nanoparticles can be tailored to suppress, enhance, or subvert recognition by the immune system. This targeted immunomodulation' can be achieved by delivery of unmodified particles, or by modifying particles to deliver drugs, proteins/peptides, or genes to a specific site. In order to elicit the desired, beneficial immune response, considerations should be made at every step of the design process: the NP platform itself, ligands, and other modifiers, the delivery route, and the immune cells that will encounter the conjugated NPs can all impact host immune responses. For further resources related to this article, please visit the . Conflict of interest: The authors have declared no conflicts of interest for this article.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据